| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Hepatocellular | 37 | 2022 | 985 | 4.220 |
Why?
|
| Liver Neoplasms | 38 | 2022 | 1381 | 3.640 |
Why?
|
| HIV Infections | 22 | 2021 | 2038 | 1.600 |
Why?
|
| Hepatitis C | 13 | 2018 | 386 | 1.140 |
Why?
|
| alpha-Fetoproteins | 12 | 2020 | 134 | 1.070 |
Why?
|
| Veterans | 13 | 2023 | 1763 | 0.930 |
Why?
|
| Electronic Health Records | 5 | 2025 | 800 | 0.900 |
Why?
|
| Cholangiocarcinoma | 7 | 2014 | 123 | 0.870 |
Why?
|
| United States | 53 | 2025 | 11667 | 0.840 |
Why?
|
| SEER Program | 18 | 2013 | 220 | 0.820 |
Why?
|
| Bile Duct Neoplasms | 6 | 2014 | 124 | 0.820 |
Why?
|
| Bile Ducts, Intrahepatic | 6 | 2014 | 105 | 0.820 |
Why?
|
| Aged | 61 | 2025 | 21438 | 0.760 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 128 | 0.720 |
Why?
|
| Mass Screening | 7 | 2018 | 830 | 0.700 |
Why?
|
| Liver Cirrhosis | 12 | 2020 | 898 | 0.700 |
Why?
|
| Palliative Care | 2 | 2018 | 457 | 0.690 |
Why?
|
| Middle Aged | 64 | 2025 | 28998 | 0.670 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2018 | 419 | 0.670 |
Why?
|
| AIDS Serodiagnosis | 4 | 2013 | 55 | 0.650 |
Why?
|
| Social Stigma | 2 | 2018 | 86 | 0.640 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2012 | 253 | 0.630 |
Why?
|
| Patient Selection | 2 | 2017 | 737 | 0.620 |
Why?
|
| Veterans Health | 2 | 2018 | 175 | 0.610 |
Why?
|
| Population Surveillance | 8 | 2012 | 416 | 0.590 |
Why?
|
| Colorectal Neoplasms | 7 | 2012 | 632 | 0.570 |
Why?
|
| Male | 81 | 2025 | 64967 | 0.570 |
Why?
|
| Housing | 1 | 2018 | 54 | 0.560 |
Why?
|
| Female | 82 | 2025 | 70695 | 0.560 |
Why?
|
| Hospice Care | 1 | 2018 | 31 | 0.550 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2013 | 496 | 0.550 |
Why?
|
| Hernia, Ventral | 5 | 2014 | 38 | 0.520 |
Why?
|
| HIV | 3 | 2018 | 187 | 0.520 |
Why?
|
| Patient Compliance | 4 | 2012 | 473 | 0.520 |
Why?
|
| Humans | 108 | 2025 | 132089 | 0.520 |
Why?
|
| Health Services Accessibility | 5 | 2019 | 669 | 0.480 |
Why?
|
| Telemedicine | 1 | 2022 | 495 | 0.480 |
Why?
|
| Medical Staff, Hospital | 2 | 2012 | 98 | 0.460 |
Why?
|
| United States Department of Veterans Affairs | 12 | 2025 | 691 | 0.460 |
Why?
|
| Hospitalization | 4 | 2019 | 1900 | 0.460 |
Why?
|
| Klatskin Tumor | 1 | 2014 | 6 | 0.450 |
Why?
|
| Incidence | 22 | 2016 | 3379 | 0.450 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 1538 | 0.440 |
Why?
|
| Adult | 39 | 2025 | 31575 | 0.440 |
Why?
|
| HIV Antibodies | 2 | 2012 | 70 | 0.440 |
Why?
|
| Ambulatory Care | 3 | 2012 | 410 | 0.430 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2015 | 482 | 0.430 |
Why?
|
| Herniorrhaphy | 5 | 2014 | 78 | 0.420 |
Why?
|
| Hepatitis B | 4 | 2013 | 172 | 0.410 |
Why?
|
| Cohort Studies | 19 | 2018 | 5168 | 0.400 |
Why?
|
| HIV Seronegativity | 1 | 2013 | 30 | 0.400 |
Why?
|
| Aged, 80 and over | 20 | 2018 | 7104 | 0.400 |
Why?
|
| Dementia | 7 | 2012 | 459 | 0.390 |
Why?
|
| Hepacivirus | 2 | 2013 | 272 | 0.390 |
Why?
|
| Sexual Partners | 1 | 2013 | 85 | 0.390 |
Why?
|
| Logistic Models | 11 | 2014 | 1839 | 0.390 |
Why?
|
| Inpatients | 2 | 2017 | 552 | 0.380 |
Why?
|
| Surgical Wound Infection | 5 | 2014 | 273 | 0.380 |
Why?
|
| Retrospective Studies | 30 | 2020 | 17416 | 0.370 |
Why?
|
| Truth Disclosure | 1 | 2013 | 105 | 0.370 |
Why?
|
| Referral and Consultation | 3 | 2014 | 568 | 0.360 |
Why?
|
| Viral Load | 5 | 2020 | 404 | 0.350 |
Why?
|
| Aggression | 5 | 2012 | 227 | 0.340 |
Why?
|
| Outpatients | 1 | 2013 | 274 | 0.340 |
Why?
|
| Algorithms | 8 | 2020 | 1722 | 0.340 |
Why?
|
| Hepatitis C, Chronic | 3 | 2018 | 370 | 0.340 |
Why?
|
| Pancreatectomy | 2 | 2009 | 149 | 0.340 |
Why?
|
| Pancreatic Neoplasms | 4 | 2010 | 729 | 0.330 |
Why?
|
| Socioeconomic Factors | 5 | 2025 | 902 | 0.310 |
Why?
|
| Texas | 12 | 2015 | 3629 | 0.310 |
Why?
|
| Survival Rate | 13 | 2014 | 2194 | 0.290 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 1460 | 0.290 |
Why?
|
| Risk Factors | 20 | 2018 | 10946 | 0.280 |
Why?
|
| Prevalence | 7 | 2014 | 2658 | 0.280 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 1015 | 0.270 |
Why?
|
| Patient-Centered Care | 2 | 2021 | 237 | 0.270 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 41 | 0.260 |
Why?
|
| Overweight | 1 | 2010 | 383 | 0.260 |
Why?
|
| Databases, Factual | 3 | 2025 | 1229 | 0.260 |
Why?
|
| Digestive System Diseases | 1 | 2007 | 20 | 0.260 |
Why?
|
| Databases as Topic | 1 | 2007 | 76 | 0.260 |
Why?
|
| Medicare | 6 | 2013 | 448 | 0.250 |
Why?
|
| Emergency Service, Hospital | 3 | 2025 | 1170 | 0.240 |
Why?
|
| Peer Group | 3 | 2018 | 121 | 0.230 |
Why?
|
| Prenatal Care | 3 | 2013 | 359 | 0.230 |
Why?
|
| Continuity of Patient Care | 3 | 2018 | 152 | 0.230 |
Why?
|
| Registries | 6 | 2016 | 1581 | 0.230 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 88 | 0.220 |
Why?
|
| Surgical Stomas | 2 | 2014 | 10 | 0.220 |
Why?
|
| Nurses | 1 | 2025 | 74 | 0.220 |
Why?
|
| Wound Closure Techniques | 2 | 2014 | 27 | 0.210 |
Why?
|
| Natural Language Processing | 2 | 2016 | 74 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2016 | 900 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2010 | 923 | 0.210 |
Why?
|
| Prognosis | 12 | 2016 | 5014 | 0.210 |
Why?
|
| Treatment Outcome | 13 | 2018 | 13034 | 0.210 |
Why?
|
| Diabetes Complications | 1 | 2005 | 207 | 0.200 |
Why?
|
| Metabolic Syndrome | 3 | 2015 | 364 | 0.200 |
Why?
|
| Postoperative Complications | 4 | 2014 | 3142 | 0.200 |
Why?
|
| Decision Support Techniques | 3 | 2015 | 310 | 0.200 |
Why?
|
| Age Distribution | 7 | 2006 | 438 | 0.200 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 698 | 0.200 |
Why?
|
| Psychomotor Agitation | 3 | 2012 | 57 | 0.190 |
Why?
|
| Alanine Transaminase | 3 | 2018 | 162 | 0.190 |
Why?
|
| Quality Indicators, Health Care | 1 | 2025 | 235 | 0.190 |
Why?
|
| Age Factors | 11 | 2018 | 2916 | 0.180 |
Why?
|
| International Classification of Diseases | 2 | 2016 | 98 | 0.180 |
Why?
|
| Regression Analysis | 5 | 2012 | 795 | 0.180 |
Why?
|
| Labor, Obstetric | 2 | 2012 | 102 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 1132 | 0.170 |
Why?
|
| Patient Transfer | 1 | 2021 | 110 | 0.170 |
Why?
|
| Time Factors | 8 | 2015 | 6448 | 0.160 |
Why?
|
| Pain | 3 | 2012 | 457 | 0.160 |
Why?
|
| Epidemiologic Methods | 3 | 2011 | 99 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2022 | 1444 | 0.150 |
Why?
|
| Delivery, Obstetric | 2 | 2012 | 267 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 724 | 0.150 |
Why?
|
| Sexual and Gender Minorities | 1 | 2020 | 72 | 0.150 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2017 | 231 | 0.150 |
Why?
|
| Sex Distribution | 6 | 2006 | 328 | 0.150 |
Why?
|
| Sex Factors | 7 | 2016 | 1355 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2004 | 768 | 0.140 |
Why?
|
| Health Care Surveys | 3 | 2016 | 294 | 0.140 |
Why?
|
| Communication | 1 | 2022 | 543 | 0.140 |
Why?
|
| Homosexuality, Male | 2 | 2020 | 72 | 0.140 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 178 | 0.130 |
Why?
|
| Anti-HIV Agents | 4 | 2015 | 348 | 0.130 |
Why?
|
| Young Adult | 7 | 2017 | 9958 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 2140 | 0.130 |
Why?
|
| Public Health Practice | 1 | 2016 | 20 | 0.130 |
Why?
|
| Colostomy | 2 | 2014 | 28 | 0.130 |
Why?
|
| Risk Adjustment | 2 | 2014 | 58 | 0.130 |
Why?
|
| Ileostomy | 2 | 2014 | 32 | 0.130 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 30 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 491 | 0.120 |
Why?
|
| Chemoembolization, Therapeutic | 2 | 2015 | 27 | 0.120 |
Why?
|
| Early Detection of Cancer | 3 | 2020 | 414 | 0.120 |
Why?
|
| Patient Participation | 1 | 2018 | 240 | 0.120 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 64 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2025 | 4003 | 0.120 |
Why?
|
| Pregnancy | 3 | 2013 | 7555 | 0.120 |
Why?
|
| Health Policy | 2 | 2014 | 233 | 0.110 |
Why?
|
| Hospitals, Urban | 2 | 2015 | 97 | 0.110 |
Why?
|
| Remote Consultation | 1 | 2014 | 25 | 0.110 |
Why?
|
| Follow-Up Studies | 9 | 2016 | 5416 | 0.110 |
Why?
|
| Cities | 1 | 2014 | 49 | 0.110 |
Why?
|
| Poisson Distribution | 2 | 2012 | 51 | 0.110 |
Why?
|
| Health Plan Implementation | 1 | 2014 | 44 | 0.110 |
Why?
|
| Pandemics | 1 | 2022 | 1183 | 0.110 |
Why?
|
| Interpersonal Relations | 3 | 2012 | 233 | 0.110 |
Why?
|
| Patient Care Management | 1 | 2014 | 65 | 0.110 |
Why?
|
| Mentors | 2 | 2016 | 163 | 0.110 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2014 | 39 | 0.110 |
Why?
|
| BRCA2 Protein | 1 | 2014 | 51 | 0.110 |
Why?
|
| Caregivers | 4 | 2012 | 595 | 0.100 |
Why?
|
| Surgical Mesh | 1 | 2014 | 67 | 0.100 |
Why?
|
| Survival Analysis | 6 | 2016 | 1573 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 81 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 44 | 0.100 |
Why?
|
| Ultrasonography | 3 | 2018 | 988 | 0.100 |
Why?
|
| Emergency Treatment | 1 | 2014 | 86 | 0.100 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2013 | 52 | 0.100 |
Why?
|
| Southwestern United States | 1 | 2013 | 45 | 0.100 |
Why?
|
| Hospitals, County | 1 | 2013 | 22 | 0.100 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 223 | 0.100 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 161 | 0.100 |
Why?
|
| Suture Techniques | 1 | 2014 | 190 | 0.100 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2012 | 54 | 0.100 |
Why?
|
| Longitudinal Studies | 5 | 2025 | 1500 | 0.100 |
Why?
|
| Centralized Hospital Services | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 141 | 0.090 |
Why?
|
| Trust | 1 | 2013 | 83 | 0.090 |
Why?
|
| Risk Assessment | 5 | 2015 | 3739 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1163 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 2648 | 0.090 |
Why?
|
| Health Personnel | 2 | 2014 | 549 | 0.090 |
Why?
|
| Serum | 1 | 2011 | 43 | 0.090 |
Why?
|
| Motivational Interviewing | 1 | 2012 | 48 | 0.090 |
Why?
|
| Public Health | 1 | 2013 | 281 | 0.090 |
Why?
|
| Gynecology | 1 | 2012 | 129 | 0.090 |
Why?
|
| Coinfection | 1 | 2013 | 189 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 3011 | 0.090 |
Why?
|
| Body Mass Index | 2 | 2014 | 1697 | 0.090 |
Why?
|
| Propensity Score | 1 | 2012 | 257 | 0.080 |
Why?
|
| Disease Progression | 2 | 2015 | 2225 | 0.080 |
Why?
|
| History, 17th Century | 1 | 2010 | 35 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 2322 | 0.080 |
Why?
|
| Primary Health Care | 2 | 2016 | 793 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 242 | 0.080 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 151 | 0.080 |
Why?
|
| Taiwan | 1 | 2010 | 62 | 0.080 |
Why?
|
| Models, Statistical | 4 | 2013 | 491 | 0.080 |
Why?
|
| Obstetrics | 1 | 2012 | 245 | 0.080 |
Why?
|
| Neoplasms | 1 | 2025 | 2957 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2013 | 425 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2009 | 1362 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 462 | 0.080 |
Why?
|
| Self-Assessment | 1 | 2009 | 65 | 0.080 |
Why?
|
| Behavior Therapy | 1 | 2012 | 269 | 0.080 |
Why?
|
| Medicare Part D | 1 | 2009 | 13 | 0.080 |
Why?
|
| Pancreas | 1 | 2010 | 222 | 0.080 |
Why?
|
| Geography | 2 | 2010 | 123 | 0.070 |
Why?
|
| Pharmaceutical Services | 1 | 2009 | 36 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2012 | 8549 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2009 | 167 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2025 | 669 | 0.070 |
Why?
|
| Hospitals | 2 | 2009 | 438 | 0.070 |
Why?
|
| Income | 1 | 2009 | 139 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2013 | 523 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2011 | 393 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2010 | 211 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2009 | 355 | 0.070 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2007 | 19 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 392 | 0.070 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2007 | 45 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 355 | 0.070 |
Why?
|
| Mortality | 2 | 2006 | 268 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 171 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 697 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 1303 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2009 | 286 | 0.060 |
Why?
|
| Platelet Count | 2 | 2018 | 139 | 0.060 |
Why?
|
| Liver Cirrhosis, Alcoholic | 2 | 2018 | 40 | 0.060 |
Why?
|
| Depression | 2 | 2012 | 1342 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2018 | 3416 | 0.060 |
Why?
|
| Social Class | 1 | 2007 | 206 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 1826 | 0.060 |
Why?
|
| Documentation | 1 | 2007 | 121 | 0.060 |
Why?
|
| Physicians | 1 | 2012 | 642 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1977 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2169 | 0.060 |
Why?
|
| Endoscopy | 1 | 2007 | 289 | 0.060 |
Why?
|
| Iowa | 1 | 2004 | 13 | 0.060 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2005 | 23 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 262 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2013 | 1254 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2019 | 453 | 0.050 |
Why?
|
| Rectal Neoplasms | 1 | 2005 | 81 | 0.050 |
Why?
|
| Health Priorities | 1 | 2023 | 37 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2007 | 384 | 0.050 |
Why?
|
| Wales | 1 | 2002 | 8 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 3766 | 0.050 |
Why?
|
| England | 1 | 2002 | 62 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2018 | 6572 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2009 | 649 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 854 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2009 | 1439 | 0.050 |
Why?
|
| Health Services Research | 1 | 2023 | 186 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2005 | 422 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1659 | 0.050 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2016 | 59 | 0.040 |
Why?
|
| Adolescent | 4 | 2015 | 20560 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 1248 | 0.040 |
Why?
|
| Depressive Disorder | 2 | 2010 | 476 | 0.040 |
Why?
|
| Linear Models | 1 | 2003 | 713 | 0.040 |
Why?
|
| Lebanon | 1 | 2020 | 11 | 0.040 |
Why?
|
| Alcoholism | 1 | 2003 | 250 | 0.040 |
Why?
|
| Reoperation | 2 | 2014 | 853 | 0.040 |
Why?
|
| Colon | 1 | 2003 | 370 | 0.040 |
Why?
|
| ROC Curve | 2 | 2013 | 601 | 0.040 |
Why?
|
| Recurrence | 2 | 2014 | 1469 | 0.040 |
Why?
|
| Medication Adherence | 2 | 2013 | 329 | 0.040 |
Why?
|
| Smoking | 1 | 2003 | 940 | 0.030 |
Why?
|
| Length of Stay | 2 | 2013 | 1380 | 0.030 |
Why?
|
| Self Report | 1 | 2021 | 549 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 2018 | 86 | 0.030 |
Why?
|
| Mental Health | 1 | 2021 | 372 | 0.030 |
Why?
|
| Obesity | 2 | 2013 | 2395 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 311 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2016 | 62 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 3092 | 0.030 |
Why?
|
| Personality Disorders | 1 | 1999 | 169 | 0.030 |
Why?
|
| Health Services | 1 | 2016 | 69 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 3407 | 0.030 |
Why?
|
| District of Columbia | 1 | 2014 | 17 | 0.030 |
Why?
|
| Financial Support | 1 | 2014 | 8 | 0.030 |
Why?
|
| Videoconferencing | 1 | 2014 | 22 | 0.030 |
Why?
|
| Antipsychotic Agents | 2 | 2010 | 381 | 0.030 |
Why?
|
| Comorbidity | 2 | 2016 | 1611 | 0.030 |
Why?
|
| Hernia, Abdominal | 1 | 2014 | 18 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2014 | 102 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2014 | 100 | 0.030 |
Why?
|
| Urban Population | 1 | 2015 | 245 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 135 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 277 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2015 | 562 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2014 | 223 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2012 | 77 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 589 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2013 | 232 | 0.020 |
Why?
|
| Data Collection | 1 | 2013 | 391 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2013 | 262 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 333 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 158 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2010 | 120 | 0.020 |
Why?
|
| Calibration | 1 | 2010 | 99 | 0.020 |
Why?
|
| Psychology | 1 | 2010 | 58 | 0.020 |
Why?
|
| Community Mental Health Services | 1 | 2010 | 39 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 2899 | 0.020 |
Why?
|
| Family Relations | 1 | 2010 | 71 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 122 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2013 | 512 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2009 | 20 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2010 | 77 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 143 | 0.020 |
Why?
|
| Global Health | 1 | 2014 | 644 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 266 | 0.020 |
Why?
|
| Nursing Homes | 1 | 2010 | 97 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2014 | 1057 | 0.020 |
Why?
|
| Medicare Part C | 1 | 2009 | 34 | 0.020 |
Why?
|
| Informed Consent | 1 | 2011 | 347 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2010 | 346 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2010 | 285 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 1799 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2013 | 822 | 0.020 |
Why?
|
| California | 1 | 2007 | 139 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 322 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2014 | 1122 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3831 | 0.020 |
Why?
|
| Motor Activity | 1 | 2009 | 523 | 0.020 |
Why?
|
| Educational Status | 1 | 2007 | 294 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2007 | 102 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2009 | 568 | 0.010 |
Why?
|
| Health Facility Size | 1 | 2005 | 5 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 435 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 991 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1294 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 6228 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1999 | 430 | 0.010 |
Why?
|
| Quality of Life | 1 | 2005 | 2161 | 0.010 |
Why?
|